Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii

被引:111
作者
Chusri, Sarunyou [1 ,2 ,3 ]
Chongsuvivatwong, Virasakdi [3 ]
Rivera, Jesabel I. [2 ]
Silpapojakul, Kachornsakdi [1 ]
Singkhamanan, Kamonnut [4 ]
McNeil, Edward [3 ]
Doi, Yohei [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Div Infect Dis, Hat Yai, Thailand
[2] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA
[3] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand
[4] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Thailand
基金
美国国家卫生研究院;
关键词
ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BAUMANNII; IDENTIFICATION; BACTEREMIA; EPIDEMIOLOGY; EMERGENCE; TESTS; SPP; GENE;
D O I
10.1128/AAC.02992-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of Acinetobacter nosocomialis and Acinetobacter pittii, which belong to the A. calcoaceticus-A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort study of hospital-acquired A. calcoaceticus-A. baumannii complex infections at a university hospital in Thailand. A total of 222 unique cases were identified between January 2010 and December 2011. The genomospecies of the A. calcoaceticus-A. baumannii complex isolates were classified as follows: A. baumannii, 197 (89%); A. nosocomialis, 18 (8%); and A. pittii, 7 (3%). All A. nosocomialis and A. pittii isolates were susceptible to imipenem and meropenem. The patients infected with A. nosocomialis and A. pittii had lower 30-day mortality than those infected with carbapenem-susceptible A. baumannii (P = 0.025) and carbapenem-resistant A. baumannii (P = 0.013). The factors influencing 30-day mortality were infection with non-baumannii A. calcoaceticus-A. baumannii complex (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.03 to 0.51; P = 0.004), infection with carbapenem-resistant A. baumannii (HR, 1.57; 95% CI, 0.89 to 2.79; P = 0.105), appropriate empirical antimicrobial therapy (HR, 0.38; 95% CI, 0.23 to 0.61; P < 0.001), and higher acute physiology and chronic health evaluation II (APACHE II) score (HR, 1.15; 95% CI, 1.10 to 1.19; P < 0.001). In Galleria mellonella assays, the survival rates were significantly higher for the larvae infected with A. nosocomialis or A. pittii than for those infected with either carbapenem-susceptible A. baumannii or carbapenem-resistant A. baumannii, but no differences in survival rates were observed between carbapenem-susceptible A. baumannii and carbapenem-resistant A. baumannii. These findings suggest intrinsic differences in virulence between non-baumannii A. calcoaceticus-A. baumannii complex species and A. baumannii but not between carbapenem-susceptible and resistant A. baumannii.
引用
收藏
页码:4172 / 4179
页数:8
相关论文
共 26 条
[11]   Emergence of Carbapenem-Resistant Non-baumannii Species of Acinetobacter Harboring a blaOXA-51-Like Gene That Is Intrinsic to A. baumannii [J].
Lee, Yi-Tzu ;
Kuo, Shu-Chen ;
Chiang, Mei-Chun ;
Yang, Su-Pen ;
Chen, Chien-Pei ;
Chen, Te-Li ;
Fung, Chang-Phone .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) :1124-1127
[12]   Acinetobacter baumannii:: Epidemiology, antimicrobial resistance, and treatment options [J].
Maragakis, Lisa L. ;
Perl, Trish M. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) :1254-1263
[13]   Current concepts: Acinetobacter infection [J].
Munoz-Price, L. Silvia ;
Weinstein, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12) :1271-1281
[14]   Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp nov (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp nov (formerly Acinetobacter genomic species 13TU) [J].
Nemec, Alexandr ;
Krizova, Lenka ;
Maixnerova, Martina ;
van der Reijden, Tanny J. K. ;
Deschaght, Pieter ;
Passet, Virginie ;
Vaneechoutte, Mario ;
Brisse, Sylvain ;
Dijkshoorn, Lenie .
RESEARCH IN MICROBIOLOGY, 2011, 162 (04) :393-404
[15]   The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies [J].
Park, Kyung-Hwa ;
Shin, Jong-Hee ;
Lee, Seung Yeop ;
Kim, Soo Hyun ;
Jang, Mi Ok ;
Kang, Seung-Ji ;
Jung, Sook-In ;
Chung, Eun-Kyung ;
Ko, Kwan Soo ;
Jang, Hee-Chang .
PLOS ONE, 2013, 8 (06)
[16]   Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea [J].
Park, Young Kyoung ;
Jung, Sook-In ;
Park, Kyong-Hwa ;
Kim, Su Hwan ;
Ko, Kwan Soo .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (01) :81-85
[17]   The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species [J].
Paterson, David L. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 :S43-S48
[18]   Acinetobacter baumannii:: Emergence of a successful pathogen [J].
Peleg, Anton Y. ;
Seifert, Harald ;
Paterson, David L. .
CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (03) :538-582
[19]   Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics [J].
Peleg, Anton Y. ;
Jara, Sebastian ;
Monga, Divya ;
Eliopoulos, George M. ;
Moellering, Robert C., Jr. ;
Mylonakis, Eleftherios .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) :2605-2609
[20]  
Rongrungruang Yong, 2013, Journal of the Medical Association of Thailand, V96, pS117